Cargando…

Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy

Background and Objectives: Retinal pigment epitheliopathy and hyperpermeability of choroidal vessels were postulated to be involved in the pathogenesis of central serous chorioretinopathy (CSC). Imbalanced levels of vascular endothelial growth factor (VEGF) and pigment-epithelium–derived factor (PED...

Descripción completa

Detalles Bibliográficos
Autores principales: Chrząszcz, Michał, Pociej-Marciak, Weronika, Żuber-Łaskawiec, Katarzyna, Romanowska-Dixon, Bożena, Sanak, Marek, Michalska-Małecka, Katarzyna, Petrovič, Mojca Globočnik, Karska-Basta, Izabella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540423/
https://www.ncbi.nlm.nih.gov/pubmed/34684100
http://dx.doi.org/10.3390/medicina57101063
_version_ 1784588983459643392
author Chrząszcz, Michał
Pociej-Marciak, Weronika
Żuber-Łaskawiec, Katarzyna
Romanowska-Dixon, Bożena
Sanak, Marek
Michalska-Małecka, Katarzyna
Petrovič, Mojca Globočnik
Karska-Basta, Izabella
author_facet Chrząszcz, Michał
Pociej-Marciak, Weronika
Żuber-Łaskawiec, Katarzyna
Romanowska-Dixon, Bożena
Sanak, Marek
Michalska-Małecka, Katarzyna
Petrovič, Mojca Globočnik
Karska-Basta, Izabella
author_sort Chrząszcz, Michał
collection PubMed
description Background and Objectives: Retinal pigment epitheliopathy and hyperpermeability of choroidal vessels were postulated to be involved in the pathogenesis of central serous chorioretinopathy (CSC). Imbalanced levels of vascular endothelial growth factor (VEGF) and pigment-epithelium–derived factor (PEDF) were previously implicated in the development of chorioretinal diseases characterized by increased vascular permeability. We aimed to compare the plasma levels of proangiogenic VEGF and antiangiogenic PEDF for 26 patients with acute CSC, 26 patients with chronic CSC, and 19 controls. Materials and Methods: VEGF and PEDF levels were measured using a multiplex immunoassay or enzyme-linked immunosorbent assay. Correlations with disease duration were assessed. Results: VEGF levels differed between groups (p = 0.001). They were lower in patients with acute CSC (p = 0.042) and chronic CSC (p = 0.018) than in controls. PEDF levels were similar in all groups. The VEGF-to-PEDF ratio was lower in CSC patients than in controls (p = 0.04). A negative correlation with disease duration was noted only for PEDF levels in the group with chronic CSC (rho = −0.46, p = 0.017). Discussion: Our study confirmed that patients with CSC have imbalanced levels of VEGF and PEDF. This finding may have important implications for the pathogenesis of CSC. VEGF-independent arteriogenesis rather than angiogenesis may underlie vascular abnormalities in these patients.
format Online
Article
Text
id pubmed-8540423
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85404232021-10-24 Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy Chrząszcz, Michał Pociej-Marciak, Weronika Żuber-Łaskawiec, Katarzyna Romanowska-Dixon, Bożena Sanak, Marek Michalska-Małecka, Katarzyna Petrovič, Mojca Globočnik Karska-Basta, Izabella Medicina (Kaunas) Article Background and Objectives: Retinal pigment epitheliopathy and hyperpermeability of choroidal vessels were postulated to be involved in the pathogenesis of central serous chorioretinopathy (CSC). Imbalanced levels of vascular endothelial growth factor (VEGF) and pigment-epithelium–derived factor (PEDF) were previously implicated in the development of chorioretinal diseases characterized by increased vascular permeability. We aimed to compare the plasma levels of proangiogenic VEGF and antiangiogenic PEDF for 26 patients with acute CSC, 26 patients with chronic CSC, and 19 controls. Materials and Methods: VEGF and PEDF levels were measured using a multiplex immunoassay or enzyme-linked immunosorbent assay. Correlations with disease duration were assessed. Results: VEGF levels differed between groups (p = 0.001). They were lower in patients with acute CSC (p = 0.042) and chronic CSC (p = 0.018) than in controls. PEDF levels were similar in all groups. The VEGF-to-PEDF ratio was lower in CSC patients than in controls (p = 0.04). A negative correlation with disease duration was noted only for PEDF levels in the group with chronic CSC (rho = −0.46, p = 0.017). Discussion: Our study confirmed that patients with CSC have imbalanced levels of VEGF and PEDF. This finding may have important implications for the pathogenesis of CSC. VEGF-independent arteriogenesis rather than angiogenesis may underlie vascular abnormalities in these patients. MDPI 2021-10-05 /pmc/articles/PMC8540423/ /pubmed/34684100 http://dx.doi.org/10.3390/medicina57101063 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chrząszcz, Michał
Pociej-Marciak, Weronika
Żuber-Łaskawiec, Katarzyna
Romanowska-Dixon, Bożena
Sanak, Marek
Michalska-Małecka, Katarzyna
Petrovič, Mojca Globočnik
Karska-Basta, Izabella
Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy
title Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy
title_full Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy
title_fullStr Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy
title_full_unstemmed Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy
title_short Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy
title_sort changes in plasma vegf and pedf levels in patients with central serous chorioretinopathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540423/
https://www.ncbi.nlm.nih.gov/pubmed/34684100
http://dx.doi.org/10.3390/medicina57101063
work_keys_str_mv AT chrzaszczmichał changesinplasmavegfandpedflevelsinpatientswithcentralserouschorioretinopathy
AT pociejmarciakweronika changesinplasmavegfandpedflevelsinpatientswithcentralserouschorioretinopathy
AT zuberłaskawieckatarzyna changesinplasmavegfandpedflevelsinpatientswithcentralserouschorioretinopathy
AT romanowskadixonbozena changesinplasmavegfandpedflevelsinpatientswithcentralserouschorioretinopathy
AT sanakmarek changesinplasmavegfandpedflevelsinpatientswithcentralserouschorioretinopathy
AT michalskamałeckakatarzyna changesinplasmavegfandpedflevelsinpatientswithcentralserouschorioretinopathy
AT petrovicmojcaglobocnik changesinplasmavegfandpedflevelsinpatientswithcentralserouschorioretinopathy
AT karskabastaizabella changesinplasmavegfandpedflevelsinpatientswithcentralserouschorioretinopathy